Accelerating an Oncology Drug Launch

An F1000 pharmaceutical company had fallen behind schedule on introducing their oncology drug to market and needed external support to develop and accelerate a launch strategy.

Business Talent Group (BTG) delivered a McKinsey-trained life science specialist with a background in project management and executive experience at two prominent biotechnology companies, who started by generating pre-launch insights, analytics, and country-level revenue forecasts before refining and implementing the renewed drug launch strategy. The talent also coordinated vendors and stakeholders to accelerate the rollout, drove accountability across multiple functions involved in the launch, and tracked brand performance and perception to ensure an effective launch.

Previous Article
Right-Sized Consulting for Digital Health Investments
Right-Sized Consulting for Digital Health Investments

A large pharma company with several novel assets in the pipeline sought external support assessing digital ...

Next Article
Therapeutic Area Strategy Support for Obesity Treatments
Therapeutic Area Strategy Support for Obesity Treatments

An F500 pharma company required therapeutic area strategy support determining how to go to market in the ob...


Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!